Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

RPS6KA2

RBC: RSK3 · Substrate: Glycogen Synthase-derived peptide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Brigatinib98.50.51
Midostaurin98.50.50
Netarsudil96.60.68
Rabusertib91.10.69
Sunitinib79.50.52
Capivasertib71.80.64
Defactinib67.50.45
Darovasertib66.00.72
Ceritinib64.70.62
Bosutinib63.40.55
Nintedanib57.60.61
Repotrectinib51.50.61
Lazertinib50.30.67
Axitinib49.20.69
Selpercatinib48.90.64

Known variants

No variants catalogued.
Open in new tab